Aperio Group’s Cardiovascular Systems, Inc. CSII Stock Holding History

Aperio Group’s Portfolio CSII Stock Details CSII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$334K	Buy	7,636 +515	+7%	+$19.4K	﹤0.01%	2135
2020 Q3	$280K	Sell	7,121 -1,118	-14%	-$36.1K	﹤0.01%	2100
2020 Q2	$260K	Buy	8,239 +17	+0.2%	+$635	﹤0.01%	2080
2020 Q1	$289K	Buy	8,222 +181	+2%	+$7.63K	﹤0.01%	1928
2019 Q4	$391K	Sell	8,041 -331	-4%	-$15.1K	﹤0.01%	1940
2019 Q3	$398K	Buy	8,372 +887	+12%	+$41.7K	﹤0.01%	1880
2019 Q2	$321K	Buy	7,485 +2,184	+41%	+$84.8K	﹤0.01%	1994
2019 Q1	$205K	Buy	+5,301	New	+$180K	﹤0.01%	2153

Other funds holding CSII

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Aperio Group's CSII Position: Q4 2020 in Review

Aperio Group increased its Cardiovascular Systems, Inc. (CSII) stake by 7.2% in Q4 2020, buying an estimated $19.4K and bringing the position to 7,636 shares worth $334K. The position accounts for ﹤0.01% of the portfolio, ranked #2135.

Aperio Group first reported a position in CSII in Q1 2019 and has held it in 8 quarters since. The position peaked at $398K in Q3 2019. 183 funds tracked by Wall St. Rank hold CSII as of Q4 2020.

Aperio Group held 7,636 shares of Cardiovascular Systems, Inc. worth $334K as of Q4 2020.
Aperio Group bought 515 Cardiovascular Systems, Inc. shares in Q4 2020, an estimated $19.4K.
Cardiovascular Systems, Inc. made up ﹤0.01% of Aperio Group's portfolio in Q4 2020, its #2135 holding.
Aperio Group first reported a position in Cardiovascular Systems, Inc. in Q1 2019 and has held it in 8 quarters since.
Aperio Group's Cardiovascular Systems, Inc. position peaked at $398K in Q3 2019.
183 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.